Clinical trial
Prospective Cohort Study of Proximal Humeral Fractures Treated With Targon® PH+
NCT02836366 is registered in ClinicalTrials.gov with Aesculap AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Cohort Study of Proximal Humeral Fractures Treated With Targon® PH+
- Lead sponsor
- Aesculap AG
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2016
- Completion date
- April 30, 2019
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.